REVIVE Logo REVIVE Logo REVIVE Logo
GARDP Forums Retina Logo
  • About
  • The Experts
  • Webinars & Conferences
    • Webinars
    • Conferences
    • External Webinars
  • Antimicrobial Viewpoints
  • Events
  • Talk to an expert
  • JOIN US
    • Log in
    • Lost your password?
    • Create your account
  • My account
    • Logout
Loading...

  • Conferences

  • WEBINARS

    View all our past webinars.

You are here:Home-Conferences
Bootcamp: Post-Approval Economics for New Antibiotics (ASM/ESCMID 2019)

Bootcamp: Post-Approval Economics for New Antibiotics (ASM/ESCMID 2019)

3 September 2019
Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019)

Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019)

3 September 2019
Enabling Academia to Fill the Discovery Gap

Enabling Academia to Fill the Discovery Gap

24 June 2019
New initiatives to support AMR innovation (BSAC Spring Conference 2019)

New initiatives to support AMR innovation (BSAC Spring Conference 2019)

21 March 2019
Resistance testing – beyond serial passage experiments

Resistance testing – beyond serial passage experiments

14 March 2019
BSAC Antimicrobial Chemotherapy Conference 2019

BSAC Antimicrobial Chemotherapy Conference 2019

15 January 2019
Bootcamp: Preclinical Toxicology (ESCMID/ASM 2018)

Bootcamp: Preclinical Toxicology (ESCMID/ASM 2018)

4 September 2018
Bootcamp: Medicinal Chemistry (ESCMID/ASM 2018)

Bootcamp: Medicinal Chemistry (ESCMID/ASM 2018)

4 September 2018
Coping with Preclinical Toxicology Challenges

Coping with Preclinical Toxicology Challenges

10 June 2018
Alternatives to (classical) antibiotics: what will it take to convincingly develop a virulence inhibitor or similar indirect agent?

Alternatives to (classical) antibiotics: what will it take to convincingly develop a virulence inhibitor or similar indirect agent?

22 April 2018
PK-PD in support of accelerated programmes: how much is enough?

PK-PD in support of accelerated programmes: how much is enough?

22 April 2018
US regulatory tools for expedited antibacterial development programmes

US regulatory tools for expedited antibacterial development programmes

22 April 2018
  • 1
  • 2
  • Next »

Share

FacebookTwitterLinkedInRedditEmail

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

  • Antimicrobial Viewpoints (24)
  • Conferences (16)
  • Experts (100)
  • External webinars (18)
  • Uncategorized (2)
  • Webinars (29)

Search site

CONNECT

  • Twitter
  • LinkedIn
  • YouTube

  • GARDP
  • DNDi
© All Rights Reserved
Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy